We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Biocartis SA

Biocartis is a commercial stage molecular diagnostics company that develops diagnostics technology platforms for mult... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Influenza-Respiratory Virus Panel Launched for Idylla platform

By LabMedica International staff writers
Posted on 09 Dec 2015
Print article
The Idylla fully automated, real-time polymerase chain reaction based molecular diagnostics system
The Idylla fully automated, real-time polymerase chain reaction based molecular diagnostics system (Photo courtesy of Biocartis SA)
The majority of diagnostic tests currently used for respiratory viruses are rapid immunoassays which are chosen due to their low cost and convenience; however, one of the key downsides of these rapid tests is their poor sensitivity.

A fully automated, real-time polymerase chain reaction (PCR) based molecular diagnostics system, which is designed to offer fast and easy access to clinical molecular diagnostic information, anywhere and anytime has been launched for the diagnosis of respiratory infectious diseases.

The platform covers the entire process from sample to result in a time frame of 35 to 150 minutes with less than two minutes hands-on time. The platform is applicable for a wide range of clinical sample types and can analyze both ribonucleic acid (RNA) and DNA. A new panel for the platform is intended for the detection of various strains of Influenza Virus (IFV) and Respiratory Syncytial Virus (RSV).

The Idylla Respiratory IFV-RSV Panel (Biocartis Group NV; Mechelen, Belgium) is designed for the qualitative detection of nucleic acids of Influenza A, Influenza A subtype H1, Influenza A subtype H3, Influenza A subtype 2009 H1, H275Y mutation of Influenza A subtype 2009 H1, Influenza B and Respiratory Syncytial Virus (RSV) subtype A and RSV subtype B from nasopharyngeal swabs of adult and pediatric patients. The panel uses the Idylla molecular diagnostics platform to aid in the diagnosis of respiratory viral infection. The Idylla Respiratory IFV-RSV Panel received CE-IVD marking on November 18, 2015, and is being launched for commercial use in Europe and other countries recognizing the CE-marking. Janssen Diagnostics (Raritan, NJ, USA) has appointed Biocartis as co-exclusive worldwide distributor of the test.

Rudi Pauwels, PhD, CEO of Biocartis, said, “Collaboration is a key aspect of the strategy that we outlined at the time of our Initial Public Offering, in order to accelerate our menu development and speed up our commercial reach. Janssen has been a long-standing and very supportive partner of Biocartis. We are therefore delighted with the launch of such a high performance quality Idylla Respiratory IFV-RSV Panel. The combination of oncology and infectious disease tests demonstrates the versatility of our Idylla platform, one of the reasons why Janssen Diagnostics chose to work with Biocartis.”

Related Links:

Biocartis Group NV 
Janssen Diagnostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.